Valuation: Qlucore AB

Market Cap 16.52M 1.72M 1.5M 1.38M 1.27M 2.41M 165M 2.45M 6.48M 80.67M 6.44M 6.3M 278M P/E 2025
-0.35x
P/E 2026 -0.38x
Enterprise Value 14.95M 1.55M 1.36M 1.25M 1.15M 2.18M 149M 2.22M 5.87M 73.01M 5.83M 5.7M 252M EV / Sales 2025
0.21x
EV / Sales 2026 1.77x
Free-Float
23.08%
Yield 2025 *
-
Yield 2026 -
1 day+10.65%
1 week+38.76%
Current month+55.47%
1 month+7.04%
3 months-10.88%
6 months-2.74%
Current year-14.46%
1 week 0.27
Extreme 0.266
0.43
1 month 0.21
Extreme 0.213
0.44
Current year 0.21
Extreme 0.213
0.58
1 year 0.21
Extreme 0.213
1.83
3 years 0.21
Extreme 0.213
12.5
5 years 0.21
Extreme 0.213
58
10 years 0.21
Extreme 0.213
58
Manager TitleAgeSince
Chief Executive Officer 58 05/12/2006
Director of Finance/CFO - 01/02/2022
Chief Tech/Sci/R&D Officer - 07/02/2022
Director TitleAgeSince
Chairman 72 01/01/2018
Director/Board Member 68 01/01/2007
Director/Board Member 63 05/12/2006
Change 5-day change 1-year change 3-year change Capi.($)
+10.65%+38.76%-23.93%-95.52% 1.71M
+2.60%+3.47%-21.59%+14.72% 2,859B
-0.04%+1.15%-9.99%+668.59% 321B
-4.50%-2.92%+255.31%+874.57% 131B
-1.82%-1.02%+16.41%+51.46% 104B
-3.29%+0.87%+87.36%+133.53% 96.37B
-0.95%-2.82%-25.81%-8.45% 81.55B
+3.36%+7.29%-28.60%+80.09% 66.94B
+3.12%-2.37%+3.24%+60.70% 44.01B
+4.41%+2.93%-49.56%+27.61% 39B
Average +1.36%+1.64%+20.28%+180.73% 374.27B
Weighted average by Cap. +1.80%-1.16%-7.27%+106.21%

Financials

2025 2026
Net sales 18.43M 1.91M 1.67M 1.54M 1.42M 2.69M 184M 2.73M 7.23M 90.02M 7.19M 7.03M 310M 10.36M 1.08M 941K 868K 798K 1.51M 104M 1.54M 4.07M 50.61M 4.04M 3.95M 174M
Net income -20.54M -2.13M -1.86M -1.72M -1.58M -3M -205M -3.05M -8.06M -100M -8.01M -7.83M -346M -36.52M -3.79M -3.32M -3.06M -2.81M -5.33M -365M -5.42M -14.33M -178M -14.24M -13.93M -615M
Net Debt -3.26M -338K -296K -273K -251K -475K -32.56M -483K -1.28M -15.91M -1.27M -1.24M -54.85M -1.57M -163K -142K -131K -121K -229K -15.68M -233K -616K -7.66M -612K -599K -26.41M
Logo Qlucore AB
Qlucore AB (publ) is a Sweden-based company primarily engaged in the software industry. The Company’s scope of activity revolves around developing Artificial-Intelligence-based (AI-based) software dedicated to the healthcare sector. The software’s aim is to establish a platform improving cancer care in terms of treatment strategies, and more, as well as other therapy areas. What is more, the Firm develops software which is committed to data analysis in relation to medical research. The Company’s software relies on AI-based machine learning and functions by transforming data sets into explanatory visualizations. Additionally, the Firm runs three software products: Qlucore Omics Explorer, Qlucore Diagnostics, as well as Qlucore Insights.
Employees
15
Date Price Change Volume
15/07/26 SEK 0.4260 +10.65% 4,546
14/07/26 SEK 0.3850 +27.91% 2,629
13/07/26 SEK 0.3010 0.00% 29,387
10/07/26 SEK 0.3010 +13.16% 96,081
09/07/26 SEK 0.2660 -13.36% 66,025
  1. Stock Market
  2. Stocks
  3. QCORE Stock